The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in Asia

Sexually Transmitted Infections
Tim Brown, W Peerapatanapokin

Abstract

Process models offer opportunities to explore the effectiveness of different programme and policy alternatives by varying input behaviours and model parameters to reflect programmatic/policy effects. The Asian Epidemic Model (AEM) has been designed to reflect the primary groups and transmission modes driving HIV transmission in Asia. The user adjusts AEM fitting parameters until HIV prevalence outputs from the model agree with observed epidemiological trends. The AEM resultant projections are closely tied to the epidemiological and behavioural data in the country. In Thailand and Cambodia they have shown good agreement with observed epidemiological trends in surveillance populations and with changes in HIV transmission modes, AIDS cases, male:female ratios over time, and other external validation checks. By varying the input behaviours and STI trends, one can examine the impact of different prevention efforts on the future course of the epidemic. In conclusion, the AEM is a semi-empirical model, which has worked well in Asian settings. It provides a useful tool for policy and programme analysis in Asian countries.

Citations

Feb 22, 2011·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Neha S ShahAndrea Y Kim
Jun 24, 2006·Bulletin of Mathematical Biology·Nicolas BacaërJianli Ye
Oct 22, 2009·The New England Journal of Medicine·Supachai Rerks-NgarmUNKNOWN MOPH-TAVEG Investigators
Apr 15, 2010·Health Care for Women International·Mohsin Saeed KhanCecilia Stålsby Lundborg
Jan 11, 2007·AIDS Research and Human Retroviruses·Matthew E FalagasElpidoforos S Soteriades
Jul 25, 2008·Sexually Transmitted Infections·L M HeatonP O Way
May 17, 2011·BMC Infectious Diseases·Mohsin Saeed KhanCecilia Stålsby Lundborg
Jan 27, 2011·BMC Public Health·Kanitta BundhamcharoenViroj Tangcharoensathien
Nov 21, 2012·BMC International Health and Human Rights·Muhammad Ahmed AbdullahAnum Shafqat
Jan 27, 2011·Drug Design, Development and Therapy·Lena J Gamble, Qiana L Matthews
Dec 12, 2012·Bulletin of the World Health Organization·Kelsey K CaseUNKNOWN HIV Modelling Consortium
Jun 26, 2014·Journal of the International AIDS Society·Zara ShubberMarie-Claude Boily
Mar 26, 2011·Vaccine·UNKNOWN Ministry of Public Health-Thai AIDS Vaccine Evaluation Group
Nov 18, 2008·The International Journal on Drug Policy·Christina M SchumacherVu Minh Quan
Aug 9, 2008·Lancet·Stefano M BertozziAlex Coutinho
Jun 25, 2015·AIDS Research and Human Retroviruses·Nittaya PhanuphakJean Louis Excler
Jul 28, 2006·The Lancet Infectious Diseases·Padma ChandrasekaranAshok Alexander
Oct 2, 2015·The Lancet. HIV·Benjamin Johns
Mar 17, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jeremy D Goldhaber-FiebertSue J Goldie
Nov 27, 2016·Global Health Action·Kanitta BundhamcharoenViroj Tangcharoensathien
Jun 9, 2017·AIDS Research and Human Retroviruses·Hamza Arshad DarAneela Javed
Jun 10, 2016·Journal of the International AIDS Society·Sherrie L KellyDavid P Wilson
Aug 27, 2010·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Sakchai ChaiyamahapurkTawesak Nopkesorn
Dec 9, 2017·Journal of the International AIDS Society·Sarah-Jane AndersonTimothy B Hallett
Apr 27, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Lesley S ParkChaiyos Kunanusont
Feb 6, 2007·Sexually Transmitted Diseases·Joseph T F LauLinglin Zhang
Sep 25, 2007·AIDS·Mead OverSombat Thanprasertsuk

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.